What We Do
Partner with our pet owners and referring veterinarians to preserve the human-animal bond.

Provide superior veterinary clinical trial services by maintaining the gold standard in the veterinary clinical trials arena.

Educate pet owners, veterinarians, researchers and physicians about the roles they play in keeping pets happy and healthy.

Foster academic and community growth to ensure our clinical trials lead in the practice of safe, innovative, efficient and beneficial veterinary care.

Our Services
- Veterinary Anesthesia
- Image-Guided Tissue Biopsy
- Radiosynoviorthesis
- Computed tomography (CT scan)
- Cone-beam CT
- CT angiography (CTA)
- Radiation Therapy (Yttrium-90/Y-90)
- Fluoroscopy
- Liver scan
- Lung scan
- Magnetic resonance angiography (MRA)
- Magnetic resonance imaging (MRI--1.5T and 3T)
- Myelogram
- Positron emission tomography (PET scan) and PET/CT
- Spiral CT
- SPECT-CT
- Transarterial Embolization and Chemoembolization
- Whole-body cancer scan
Our Pets
Clinical Trials
Canine Cancer Clinical Trial
This clinical trial will enroll a total of 5-7 dogs in order to confirm that 18F DCFPyl PET-CT offers an improved sensitivity for the early detection of hemangiosarcoma cancer or metastatic prostate cancer.
Canine Metastatic Cancer Clinical Trial
This clinical trial will enroll 5-10 dogs to evaluate the efficacy of a novel chemotherapeutic agent called IF7-SN38. This trial includes dogs with metastatic disease. This chemotherapy is delivered intravenously as a series, every other day for three to five days.
Canine Brain Cancer Clinical Trial
This clinical trial will enroll 5-10 dogs to evaluate the efficacy of a novel chemotherapeutic agent called IF7-SN38. This chemotherapy is delivered intravenously as a series, every other day for three to five days.
Coming Soon
- Canine Prostate Cancer
Contact Information
720 Rutland Ave.
Ross Building #315
Baltimore, Maryland 21205
Telephone: 410-614-0105
Email: [email protected]